These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19443274)

  • 1. Pediatric renal cell carcinoma.
    Sausville JE; Hernandez DJ; Argani P; Gearhart JP
    J Pediatr Urol; 2009 Aug; 5(4):308-14. PubMed ID: 19443274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
    Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
    Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma in children and adolescents.
    Spreafico F; Collini P; Terenziani M; Marchianò A; Piva L
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1967-78. PubMed ID: 21110762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy.
    Rais-Bahrami S; Drabick JJ; De Marzo AM; Hicks J; Ho C; Caroe AE; Argani P
    Urology; 2007 Jul; 70(1):178.e3-6. PubMed ID: 17656236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature.
    Kunthur A; Wiernik PH; Dutcher JP
    Am J Hematol; 2006 Apr; 81(4):271-80. PubMed ID: 16550521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation carcinomas of the kidney after chemotherapy in childhood.
    Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
    J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature.
    Schafernak KT; Yang XJ; Hsueh W; Leestma JL; Stagl J; Goldman S
    Can J Urol; 2007 Dec; 14(6):3739-44. PubMed ID: 18163925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.
    Hedgepeth RC; Zhou M; Ross J
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):602-4. PubMed ID: 19636262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
    Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
    Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma: Children's Hospital Boston experience.
    Estrada CR; Suthar AM; Eaton SH; Cilento BG
    Urology; 2005 Dec; 66(6):1296-300. PubMed ID: 16360460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic investigation of kidney tumors. A supplement to conventional diagnosis].
    Pedersen RK; Kerndrup GB
    Ugeskr Laeger; 1999 Aug; 161(31):4376-9. PubMed ID: 10487099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of renal cell carcinoma after successful treatment of Wilms tumor.
    Rich BS; McEvoy MP; La Quaglia MP
    J Pediatr Surg; 2010 Sep; 45(9):1883-6. PubMed ID: 20850637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.
    Smaldone MC; Fung C; Uzzo RG; Haas NB
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):765-91. PubMed ID: 21763967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma as second malignancy in patient with previous Wilms tumor.
    Lazarus J; Moolman C
    Urology; 2009 Sep; 74(3):598-600. PubMed ID: 19523667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
    Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
    Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing family of hereditary renal cell carcinoma.
    Richard S; Lidereau R; Giraud S
    Nephrol Dial Transplant; 2004 Dec; 19(12):2954-8. PubMed ID: 15507478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.